ADMA News and Press, ADMA Biologics Inc From 08/11/22

Shares of ADMA Biologics Inc (NASDAQ:ADMA) traded today at $2.48, eclipsing its 52-week high. So far today approximately 253,000 shares have been exchanged, as compared to an average 30-day volume of 1.8 million shares. ADMA Biologics Inc is an end-to-end commercial biopharmaceutical com...

ADMA Biologics press release ( NASDAQ: ADMA ): Q2 GAAP EPS of -$0.07. Revenue of $33.9M (+90.4% Y/Y). Shares +2.8% . 2022 Financial Guidance: Enabled by the strong start to the year, ADMA anticipates total 2022 revenues will exceed $130 million. ADMA reiterates...

2Q2022 Total Revenues Were $33.9 Million, a 90% Y-o-Y Increase Grew 2Q2022 Gross Profit to $7.8 Million, Up 112% Over 1Q2022 Narrowed 2Q2022 Net Losses to $13.8 Million, a 45% Improvement Over 1Q2022 Full Year 2022 Total Revenues Expected to Exceed $130 Million ...

RAMSEY, N.J. and BOCA RATON, Fla., Aug. 03, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived bi...

3 Tips for Trading Penny Stocks in July 2022 If you’re thinking about buying and selling penny stocks in 2022, there is a lot to understand. Right now, the most important aspects to consider include what is going on in the stock market and how to take advantage. As far as the...

Shares of ADMA Biologics Inc (NASDAQ:ADMA) traded at a new 52-week high today of $2.35. Approximately 124,000 shares have changed hands today, as compared to an average 30-day volume of 3.3 million shares. ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated...

ADMA Biologics (NASDAQ:ADMA) said it received U.S. Food and Drug Administration (FDA) approval for its sixth ADMA BioCenters plasma collection facility, in Myrtle Beach, South Carolina. The company said on June 27 that the facility began operations and initiated source plasma collection in Q4...

ADMA Biologics Inc (NASDAQ:ADMA) traded at a new 52-week high today of $2.31. Approximately 201,000 shares have changed hands today, as compared to an average 30-day volume of 2.5 million shares. ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufa...

ADMA Biologics (NASDAQ:ADMA) will be added to the Russell 2000 Index, , according to a preliminary list of additions posted by FTSE Russell on June 17, 2022. The addition will be effective as of market open on June 27, 2022. Shares -2.73% PM For further details see: ADMA biolo...

Ramsey, N.J. and Boca Raton, Fla., June 21, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived bi...